Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00148759 · ClinicalTrials.gov registry record · Phase 4
Kaletra Sex/Gender Pharmacokinetics (PK) Study
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 23
- Enrollment target
NCT00148759 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 23 participants.
The verdict
NCT00148759, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 23 participants
- Enrollment target
Study Summary
The levels of lopinavir achieved in the blood following oral ingestion of standard doses of Kaletra (lopinavir/ritonavir) in HIV-infected men was compared with those achieved in HIV-infected women receiving the same dose of the drug.
Interventions
- DRUG LPV/r
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2005-06 |
| Est. Completion | 2007-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00148759
The ClinicalTrials.gov registry entry for NCT00148759 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LPV/r is the first listed.
NCT00148759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00148759 about?
NCT00148759 is a clinical study titled "Kaletra Sex/Gender Pharmacokinetics (PK) Study". The levels of lopinavir achieved in the blood following oral ingestion of standard doses of Kaletra (lopinavir/ritonavir) in HIV-infected men was compared with those achieved in HIV-infected women receiving the same dose of the drug.
What is the current status of trial NCT00148759?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 23 participants. The study started on 2005-06. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00148759?
The interventions under investigation include: LPV/r (DRUG).
Who is sponsoring clinical trial NCT00148759?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.